Neuroanatomical changes in the median nerve following surgical release in moderate-to-severe carpal tunnel syndrome
Metadatos
Mostrar el registro completo del ítemAutor
Expósito Tirado, Jose Antonio; Delgado Mendilivar, José María; Angulo Gutierrez, Jorge; Peirau Gabarrell, Martí; Díaz del Río, Juana; Salvador Camacho, Julio; García Serrano, María del Carmen; Del Pino Algarrada, Rogelio; Praena Fernández, Juan Manuel; Vergara Diaz, Gloria PatriciaEditorial
Elsevier
Materia
Carpal tunnel syndrome Median nerve ultrasound
Fecha
2025-11-20Referencia bibliográfica
Published version: Jose Antonio Expósito-Tirado et al. Neuroanatomical´ changes in the median nerve following surgical release in moderate-to-severe carpal tunnel syn drome., Archives of Physical Medicine and Rehabilitation (2025), https://doi.org/10.1016/j.apmr. 2025.10.027
Patrocinador
Mutua Madrileña Foundation - (AP176862021)Resumen
Objective
To primarily assess neuroanatomical changes following CTS surgical release and their association with patient symptoms and functional status; secondarily, to determine the optimal time point for evaluating therapeutic outcomes.
Design
Prospective quasi-experimental study with a follow-up period of 6 months.
Setting
Physical medicine and rehabilitation institutional practice in an outpatient setting.
Participants
34 patients diagnosed with moderate-to-severe CTS by ultrasound, who underwent surgical release between May 2022 and July 2023.
Interventions
Median nerve surgical release.
Main Outcome Measures
Ultrasound was used to assess the cross-sectional area (CSA) and flattening ratio (FR) of the median nerve before surgery and at 15 days, three months, and six months postoperatively. The Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) was administered to assess symptom severity and functional status.
Results
Of the participants, 73.6% were women, with a median age of 48.8 years (42.5–53.3). Before surgery, CSA at the carpal tunnel inlet measured 14.3 mm² (IQR 13–17) and at the outlet 10 mm² (IQR 9–11); the FR was 3.1 (2.5; 3.7). The CSA at the inlet was the only parameter to show consistent improvement at all follow-up points: 15 days (p=0.001), three months (p<0.001), and six months (p<0.001). BCTQ scores for symptom severity and functional status showed significant reduction at three and six months (p<0.001).
Conclusion
A reduction in the elevated CSA of the median nerve was observed following CTS surgical release, with the optimal evaluation point being three months postoperatively. This anatomical improvement was associated with decreased symptom severity and improved functional status.





